Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2016 (2016), Article ID 8254942, 19 pages
http://dx.doi.org/10.1155/2016/8254942
Review Article

The Role of Mitochondrial Reactive Oxygen Species in Cardiovascular Injury and Protective Strategies

1Department of Pathophysiology, Victor Babeș University of Medicine and Pharmacy, 2 Eftimie Murgu Square, 300041 Timișoara, Romania
2Center for Translational Research and Systems Medicine, Victor Babeș University of Medicine and Pharmacy, 2 Eftimie Murgu Square, 300041 Timișoara, Romania
3Department of Cardiology-2nd Cardiology Clinic, Victor Babeș University of Medicine and Pharmacy, 2 Eftimie Murgu Square, 300041 Timișoara, Romania

Received 21 February 2016; Revised 29 March 2016; Accepted 30 March 2016

Academic Editor: Mohanraj Rajesh

Copyright © 2016 Danina M. Muntean et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. S. Go, D. Mozaffarian, V. L. Roger et al., “Heart disease and stroke statistics—2014 update: a report from the American Heart Association,” Circulation, vol. 129, no. 3, pp. e28–e292, 2014. View at Publisher · View at Google Scholar
  2. C. D. Mathers and D. Loncar, “Projections of global mortality and burden of disease from 2002 to 2030,” PLoS Medicine, vol. 3, no. 11, article e442, 2002. View at Google Scholar
  3. G. M. Fröhlich, P. Meier, S. K. White, D. M. Yellon, and D. J. Hausenloy, “Myocardial reperfusion injury: looking beyond primary PCI,” European Heart Journal, vol. 34, no. 23, pp. 1714–1722, 2013. View at Publisher · View at Google Scholar · View at Scopus
  4. E. Braunwald and R. A. Kloner, “Myocardial reperfusion: a double-edged sword?” The Journal of Clinical Investigation, vol. 76, no. 5, pp. 1713–1719, 1985. View at Publisher · View at Google Scholar · View at Scopus
  5. D. J. Hearse, “Ischemia, reperfusion, and the determinants of tissue injury,” Cardiovascular Drugs and Therapy, vol. 4, supplement 4, pp. 767–776, 1990. View at Publisher · View at Google Scholar · View at Scopus
  6. S. R. J. Maxwell and G. Y. H. Lip, “Reperfusion injury: a review of the pathophysiology, clinical manifestations and therapeutic options,” International Journal of Cardiology, vol. 58, no. 2, pp. 95–117, 1997. View at Publisher · View at Google Scholar · View at Scopus
  7. D. M. Yellon and D. J. Hausenloy, “Myocardial reperfusion injury,” The New England Journal of Medicine, vol. 357, no. 11, pp. 1074–1135, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. R. B. Jennings, “Historical perspective on the pathology of myocardial ischemia/reperfusion injury,” Circulation Research, vol. 113, no. 4, pp. 428–438, 2013. View at Publisher · View at Google Scholar · View at Scopus
  9. R. A. Kloner, “Does reperfusion injury exist in humans?” Journal of the American College of Cardiology, vol. 21, no. 2, pp. 537–545, 1993. View at Publisher · View at Google Scholar · View at Scopus
  10. G. Heusch and R. Schulz, “Little evidence for lethal reperfusion injury to cardiomyocytes,” Journal of Thrombosis and Thrombolysis, vol. 4, no. 1, pp. 111–112, 1997. View at Publisher · View at Google Scholar · View at Scopus
  11. S. B. Ong and A. B. Gustafsson, “New roles for mitochondria in cell death in the reperfused myocardium,” Cardiovascular Research, vol. 94, no. 2, pp. 190–196, 2012. View at Publisher · View at Google Scholar
  12. R. J. Diaz and G. J. Wilson, “Modifying the first minute of reperfusion: potential for myocardial salvage,” Cardiovascular Research, vol. 62, no. 1, pp. 4–6, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. H. M. Piper, Y. Abdallah, and C. Schäfer, “The first minutes of reperfusion: a window of opportunity for cardioprotection,” Cardiovascular Research, vol. 61, no. 3, pp. 365–371, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. D. J. Hausenloy and D. M. Yellon, “Myocardial ischemia-reperfusion injury: a neglected therapeutic target,” The Journal of Clinical Investigation, vol. 123, no. 1, pp. 92–100, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. D. Garcia-Dorado, A. Rodríguez-Sinovas, M. Ruiz-Meana, and J. Inserte, “Protection against myocardial ischemia-reperfusion injury in clinical practice,” Revista Española de Cardiología, vol. 67, no. 5, pp. 394–404, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. F. Di Lisa, “Mitochondrial contribution in the progression of cardiac ischemic injury,” IUBMB Life, vol. 52, no. 3–5, pp. 255–261, 2002. View at Publisher · View at Google Scholar · View at Scopus
  17. A. L. Moens, M. J. Claeys, J. P. Timmermans, and C. J. Vrints, “Myocardial ischemia/reperfusion-injury, a clinical view on a complex pathophysiological process,” International Journal of Cardiology, vol. 100, no. 2, pp. 179–190, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. D. N. Silachev, E. Y. Plotnikov, I. B. Pevzner et al., “The mitochondrion as a key regulator of ischaemic tolerance and injury,” Heart Lung and Circulation, vol. 23, no. 10, pp. 897–904, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. A. P. Halestrap and A. P. Richardson, “The mitochondrial permeability transition: a current perspective on its identity and role in ischaemia/reperfusion injury,” Journal of Molecular and Cellular Cardiology, vol. 78, pp. 129–141, 2015. View at Publisher · View at Google Scholar · View at Scopus
  20. P. Bernardi and F. Di Lisa, “The mitochondrial permeability transition pore: molecular nature and role as a target in cardioprotection,” Journal of Molecular and Cellular Cardiology, vol. 78, pp. 100–106, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. D. Morin, T. Hauet, M. Spedding, and J.-P. Tillement, “Mitochondria as target for antiischemic drugs,” Advanced Drug Delivery Reviews, vol. 49, no. 1-2, pp. 151–174, 2001. View at Publisher · View at Google Scholar · View at Scopus
  22. A. M. Walters, G. A. Porter Jr., and P. S. Brookes, “Mitochondria as a drug target in ischemic heart disease and cardiomyopathy,” Circulation Research, vol. 111, no. 9, pp. 1222–1236, 2012. View at Publisher · View at Google Scholar
  23. A. K. Camara, M. Bienengraeber, and D. F. Stowe, “Mitochondrial approaches to protect against cardiac ischemia and reperfusion injury,” Frontiers in Physiology, vol. 2, article 13, 2011. View at Publisher · View at Google Scholar
  24. J. L. Zweier and M. A. H. Talukder, “The role of oxidants and free radicals in reperfusion injury,” Cardiovascular Research, vol. 70, no. 2, pp. 181–190, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. F. Di Lisa and P. Bernardi, “Mitochondria and ischemia-reperfusion injury of the heart: fixing a hole,” Cardiovascular Research, vol. 70, no. 2, pp. 191–199, 2006. View at Publisher · View at Google Scholar · View at Scopus
  26. D. N. Granger and P. R. Kvietys, “Reperfusion injury and reactive oxygen species: the evolution of a concept,” Redox Biology, vol. 6, pp. 524–551, 2015. View at Publisher · View at Google Scholar · View at Scopus
  27. F. Di Lisa, M. Canton, A. Carpi et al., “Mitochondrial injury and protection in ischemic pre-and postconditioning,” Antioxidants & Redox Signaling, vol. 14, no. 5, pp. 881–891, 2011. View at Publisher · View at Google Scholar · View at Scopus
  28. F. Tullio, C. Angotti, M.-G. Perrelli, C. Penna, and P. Pagliaro, “Redox balance and cardioprotection,” Basic Research in Cardiology, vol. 108, no. 6, article 392, 2013. View at Publisher · View at Google Scholar · View at Scopus
  29. T. Kalogeris, Y. Bao, and R. J. Korthuis, “Mitochondrial reactive oxygen species: a double edged sword in ischemia/reperfusion vs preconditioning,” Redox Biology, vol. 2, no. 1, pp. 702–714, 2014. View at Publisher · View at Google Scholar · View at Scopus
  30. O. M. Duicu, D. Angoulvant, and D. M. Muntean, “Cardioprotection against myocardial reperfusion injury: successes, failures, and perspectives,” Canadian Journal of Physiology and Pharmacology, vol. 91, no. 8, pp. 657–662, 2013. View at Publisher · View at Google Scholar · View at Scopus
  31. F. Altamirano, Z. V. Wang, and J. A. Hill, “Cardioprotection in ischaemia-reperfusion injury: novel mechanisms and clinical translation,” Journal of Physiology, vol. 593, no. 17, pp. 3773–3788, 2015. View at Publisher · View at Google Scholar · View at Scopus
  32. H. A. Cabrera-Fuentes, C. Alba-Alba, J. Aragones et al., “Meeting report from the 2nd International Symposium on New Frontiers in Cardiovascular Research. Protecting the cardiovascular system from ischemia: between bench and bedside,” Basic Research in Cardiology, vol. 111, article 7, 2016. View at Publisher · View at Google Scholar
  33. J. S. Armstrong, “Mitochondria-directed therapeutics,” Antioxidants & Redox Signaling, vol. 10, no. 3, pp. 575–578, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. R. A. Smith, R. C. Hartley, H. M. Cocheme, and M. P. Murphy, “Mitochondrial pharmacology,” Trends in Pharmacological Sciences, vol. 33, no. 6, pp. 341–352, 2012. View at Google Scholar
  35. C. Reily, T. Mitchell, B. K. Chacko, G. A. Benavides, M. P. Murphy, and V. M. Darley-Usmar, “Mitochondrially targeted compounds and their impact on cellular bioenergetics,” Redox Biology, vol. 1, no. 1, pp. 86–93, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. J. P. G. Sluijter, G. Condorelli, S. M. Davidson et al., “Novel therapeutic strategies for cardioprotection,” Pharmacology & Therapeutics, vol. 144, no. 1, pp. 60–70, 2014. View at Publisher · View at Google Scholar · View at Scopus
  37. R. S. Balaban, “Perspectives on: SGP symposium on mitochondrial physiology and medicine: metabolic homeostasis of the heart,” The Journal of General Physiology, vol. 139, no. 6, pp. 407–414, 2012. View at Publisher · View at Google Scholar
  38. R. B. Jennings and W. B. Wartman, “Production of an area of homogeneous myocardial infarction in the dog,” AMA Archives of Pathology, vol. 63, no. 6, pp. 580–585, 1957. View at Google Scholar
  39. R. B. Jennings, C. E. Ganote, and K. A. Reimer, “Ischemic tissue injury,” The American Journal of Pathology, vol. 81, no. 1, pp. 179–198, 1975. View at Google Scholar
  40. R. B. Jennings and C. E. Ganote, “Mitochondrial structure and function in acute myocardial ischemic injury,” Circulation Research, vol. 38, supplement 1, no. 5, pp. 80–91, 1976. View at Google Scholar · View at Scopus
  41. A. C. Shen and R. B. Jennings, “Myocardial calcium and magnesium in acute ischemic injury,” The American Journal of Pathology, vol. 67, no. 3, pp. 417–440, 1972. View at Google Scholar
  42. V. J. Richard, C. E. Murry, R. B. Jennings, and K. A. Reimer, “Oxygen-derived free radicals and postischemic myocardial reperfusion: therapeutic implications,” Fundamental & Clinical Pharmacology, vol. 4, no. 1, pp. 85–103, 1990. View at Publisher · View at Google Scholar · View at Scopus
  43. F. Di Lisa, R. Menabò, M. Canton, and V. Petronilli, “The role of mitochondria in the salvage and the injury of the ischemic myocardium,” Biochimica et Biophysica Acta (BBA)—Bioenergetics, vol. 1366, no. 1-2, pp. 69–78, 1998. View at Publisher · View at Google Scholar · View at Scopus
  44. B. Halliwell, “Free radicals and antioxidants: updating a personal view,” Nutrition Reviews, vol. 70, no. 5, pp. 257–265, 2012. View at Publisher · View at Google Scholar · View at Scopus
  45. C. E. Ganote and J. P. Kaltenbach, “Oxygen-induced enzyme release: early events and a proposed mechanism,” Journal of Molecular and Cellular Cardiology, vol. 11, no. 4, pp. 389–406, 1979. View at Publisher · View at Google Scholar · View at Scopus
  46. R. S. Vander Heide, J. P. Angelo, R. A. Altschuld, and C. E. Ganote, “Energy dependence of contraction band formation in perfused hearts and isolated adult myocytes,” The American Journal of Pathology, vol. 125, no. 1, pp. 55–68, 1986. View at Google Scholar · View at Scopus
  47. R. A. Kloner, K. Przyklenk, and P. Whittaker, “Deleterious effects of oxygen radicals in ischemia/reperfusion. Resolved and unresolved issues,” Circulation, vol. 80, no. 5, pp. 1115–1127, 1989. View at Publisher · View at Google Scholar · View at Scopus
  48. J. M. McCord, “Free radicals and myocardial ischemia: overview and outlook,” Free Radical Biology and Medicine, vol. 4, no. 1, pp. 9–14, 1988. View at Publisher · View at Google Scholar · View at Scopus
  49. Y. Gauduel, P. Menasche, and M. Duvelleroy, “Enzyme release and mitochondrial activity in reoxygenated cardiac muscle: relationship with oxygen-induced lipid peroxidation,” General Physiology and Biophysics, vol. 8, no. 4, pp. 327–340, 1989. View at Google Scholar · View at Scopus
  50. B. Halliwell, “The wanderings of a free radical,” Free Radical Biology & Medicine, vol. 46, no. 5, pp. 531–542, 2009. View at Publisher · View at Google Scholar · View at Scopus
  51. A. Y. Andreyev, Y. E. Kushnareva, and A. A. Starkov, “Mitochondrial metabolism of reactive oxygen species,” Biochemistry (Moscow), vol. 70, no. 2, pp. 200–214, 2005. View at Publisher · View at Google Scholar · View at Scopus
  52. W. Dröge, “Free radicals in the physiological control of cell function,” Physiological Reviews, vol. 82, no. 1, pp. 47–95, 2002. View at Publisher · View at Google Scholar
  53. H. H. Schmidt, R. Stocker, C. Vollbracht et al., “Antioxidants in translational medicine,” Antioxidants & Redox Signaling, vol. 23, no. 14, pp. 1130–1143, 2015. View at Publisher · View at Google Scholar
  54. D. P. Jones, “Redefining oxidative stress,” Antioxidants & Redox Signaling, vol. 8, no. 9-10, pp. 1865–1879, 2006. View at Publisher · View at Google Scholar · View at Scopus
  55. D. P. Jones, “Radical-free biology of oxidative stress,” American Journal of Physiology—Cell Physiology, vol. 295, no. 4, pp. C849–C868, 2008. View at Publisher · View at Google Scholar
  56. M. R. Duchen, “Mitochondria in health and disease: perspectives on a new mitochondrial biology,” Molecular Aspects of Medicine, vol. 25, no. 4, pp. 365–451, 2004. View at Publisher · View at Google Scholar · View at Scopus
  57. A. Y. Andreyev, Y. E. Kushnareva, A. N. Murphy, and A. A. Starkov, “Mitochondrial ROS metabolism: 10 years later,” Biochemistry, vol. 80, no. 5, pp. 517–531, 2015. View at Publisher · View at Google Scholar
  58. B. Ibanez, V. Fuster, J. Jiménez-Borreguero, and J. J. Badimon, “Lethal myocardial reperfusion injury: a necessary evil?” International Journal of Cardiology, vol. 151, no. 1, pp. 3–11, 2011. View at Publisher · View at Google Scholar · View at Scopus
  59. J. F. Turrens, “Mitochondrial formation of reactive oxygen species,” The Journal of Physiology, vol. 552, part 2, pp. 335–344, 2003. View at Google Scholar
  60. Y. Liu, G. Fiskum, and D. Schubert, “Generation of reactive oxygen species by the mitochondrial electron transport chain,” Journal of Neurochemistry, vol. 80, no. 5, pp. 780–787, 2002. View at Publisher · View at Google Scholar · View at Scopus
  61. Q. Chen, E. J. Vazquez, S. Moghaddas, C. L. Hoppel, and E. J. Lesnefsky, “Production of reactive oxygen species by mitochondria: central role of complex III,” The Journal of Biological Chemistry, vol. 278, no. 38, pp. 36027–36031, 2003. View at Publisher · View at Google Scholar · View at Scopus
  62. V. Adam-Vizi and C. Chinopoulos, “Bioenergetics and the formation of mitochondrial reactive oxygen species,” Trends in Pharmacological Sciences, vol. 27, no. 12, pp. 639–645, 2006. View at Publisher · View at Google Scholar · View at Scopus
  63. S. Orrenius, “Reactive oxygen species in mitochondria-mediated cell death,” Drug Metabolism Reviews, vol. 39, no. 2-3, pp. 443–455, 2007. View at Publisher · View at Google Scholar · View at Scopus
  64. E. B. Tahara, F. D. T. Navarete, and A. J. Kowaltowski, “Tissue-, substrate-, and site-specific characteristics of mitochondrial reactive oxygen species generation,” Free Radical Biology & Medicine, vol. 46, no. 9, pp. 1283–1297, 2009. View at Publisher · View at Google Scholar · View at Scopus
  65. A. J. Lambert and M. D. Brand, “Reactive oxygen species production by mitochondria,” Methods in Molecular Biology, vol. 554, pp. 165–181, 2009. View at Publisher · View at Google Scholar · View at Scopus
  66. M. P. Murphy, “How mitochondria produce reactive oxygen species,” The Biochemical Journal, vol. 417, no. 1, pp. 1–13, 2009. View at Publisher · View at Google Scholar
  67. D. F. Stowe and A. K. Camara, “Mitochondrial reactive oxygen species production in excitable cells: modulators of mitochondrial and cell function,” Antioxidants & Redox Signaling, vol. 11, no. 6, pp. 1373–1414, 2009. View at Publisher · View at Google Scholar · View at Scopus
  68. T. Finkel, “Signal transduction by mitochondrial oxidants,” The Journal of Biological Chemistry, vol. 287, no. 7, pp. 4434–4440, 2012. View at Publisher · View at Google Scholar
  69. V. G. Grivennikova and A. D. Vinogradov, “Mitochondrial production of reactive oxygen species,” Biochemistry, vol. 78, no. 13, pp. 1490–1511, 2013. View at Publisher · View at Google Scholar · View at Scopus
  70. D. B. Zorov, M. Juhaszova, and S. J. Sollott, “Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release,” Physiological Reviews, vol. 94, no. 3, pp. 909–950, 2014. View at Publisher · View at Google Scholar · View at Scopus
  71. Y. R. Chen and J. L. Zweier, “Cardiac mitochondria and reactive oxygen species generation,” Circulation Research, vol. 114, no. 3, pp. 524–537, 2014. View at Publisher · View at Google Scholar
  72. M. Forkink, J. A. M. Smeitink, R. Brock, P. H. G. M. Willems, and W. J. H. Koopman, “Detection and manipulation of mitochondrial reactive oxygen species in mammalian cells,” Biochimica et Biophysica Acta (BBA)—Bioenergetics, vol. 1797, no. 6-7, pp. 1034–1044, 2010. View at Publisher · View at Google Scholar · View at Scopus
  73. N. Kaludercic, J. Mialet-Perez, N. Paolocci, A. Parini, and F. Di Lisa, “Monoamine oxidases as sources of oxidants in the heart,” Journal of Molecular and Cellular Cardiology, vol. 73, pp. 34–42, 2014. View at Publisher · View at Google Scholar · View at Scopus
  74. P. H. G. M. Willems, R. Rossignol, C. E. J. Dieteren, M. P. Murphy, and W. J. H. Koopman, “Redox homeostasis and mitochondrial dynamics,” Cell Metabolism, vol. 22, no. 2, pp. 207–218, 2015. View at Publisher · View at Google Scholar · View at Scopus
  75. J. F. Turrens and A. Boveris, “Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria,” The Biochemical Journal, vol. 191, no. 2, pp. 421–427, 1980. View at Publisher · View at Google Scholar · View at Scopus
  76. L. Kussmaul and J. Hirst, “The mechanism of superoxide production by NADH:ubiquinone oxidoreductase (complex I) from bovine heart mitochondria,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 20, pp. 7607–7612, 2006. View at Publisher · View at Google Scholar · View at Scopus
  77. S. T. Ohnishi, K. Shinzawa-Itoh, K. Ohta, S. Yoshikawa, and T. Ohnishi, “New insights into the superoxide generation sites in bovine heart NADH-ubiquinone oxidoreductase (Complex I): the significance of protein-associated ubiquinone and the dynamic shifting of generation sites between semiflavin and semiquinone radicals,” Biochimica et Biophysica Acta, vol. 1797, no. 12, pp. 1901–1909, 2010. View at Publisher · View at Google Scholar · View at Scopus
  78. M. L. Genova, B. Ventura, G. Giuliano et al., “The site of production of superoxide radical in mitochondrial Complex I is not a bound ubisemiquinone but presumably iron-sulfur cluster N2,” FEBS Letters, vol. 505, no. 3, pp. 364–368, 2001. View at Publisher · View at Google Scholar · View at Scopus
  79. P. T. Kang, L. Zhang, C. L. Chen, J. Chen, K. B. Green, and Y. R. Chen, “Protein thiyl radical mediates S-glutathionylation of complex I,” Free Radical Biology and Medicine, vol. 53, no. 4, pp. 962–973, 2012. View at Publisher · View at Google Scholar
  80. J. Chen, C.-L. Chen, S. Rawale et al., “Peptide-based antibodies against glutathione-binding domains suppress superoxide production mediated by mitochondrial complex,” The Journal of Biological Chemistry, vol. 285, no. 5, pp. 3168–3180, 2010. View at Publisher · View at Google Scholar · View at Scopus
  81. C.-L. Chen, L. Zhang, A. Yeh et al., “Site-specific S-glutathiolation of mitochondrial NADH ubiquinone reductase,” Biochemistry, vol. 46, no. 19, pp. 5754–5765, 2007. View at Publisher · View at Google Scholar · View at Scopus
  82. Y.-R. Chen, C.-L. Chen, L. Zhang, K. B. Green-Church, and J. L. Zweier, “Superoxide generation from mitochondrial NADH dehydrogenase induces self-inactivation with specific protein radical formation,” The Journal of Biological Chemistry, vol. 280, no. 45, pp. 37339–37348, 2005. View at Publisher · View at Google Scholar · View at Scopus
  83. K. R. Pryde and J. Hirst, “Superoxide is produced by the reduced flavin in mitochondrial complex I: a single, unified mechanism that applies during both forward and reverse electron transfer,” The Journal of Biological Chemistry, vol. 286, no. 20, pp. 18056–18065, 2011. View at Publisher · View at Google Scholar · View at Scopus
  84. J. St-Pierre, J. A. Buckingham, S. J. Roebuck, and M. D. Brand, “Topology of superoxide production from different sites in the mitochondrial electron transport chain,” The Journal of Biological Chemistry, vol. 277, no. 47, pp. 44784–44790, 2002. View at Publisher · View at Google Scholar · View at Scopus
  85. S. T. Ohnishi, T. Ohnishi, S. Muranaka et al., “A possible site of superoxide generation in the complex I segment of rat heart mitochondria,” Journal of Bioenergetics and Biomembranes, vol. 37, no. 1, pp. 1–15, 2005. View at Publisher · View at Google Scholar · View at Scopus
  86. Y. Kushnareva, A. N. Murphy, and A. Andreyev, “Complex I-mediated reactive oxygen species generation: modulation by cytochrome c and NAD(P)+ oxidation-reduction state,” The Biochemical Journal, vol. 368, no. 2, pp. 545–553, 2002. View at Publisher · View at Google Scholar · View at Scopus
  87. A. P. Kudin, N. Y.-B. Bimpong-Buta, S. Vielhaber, C. E. Elger, and W. S. Kunz, “Characterization of superoxide-producing sites in isolated brain mitochondria,” The Journal of Biological Chemistry, vol. 279, no. 6, pp. 4127–4135, 2004. View at Publisher · View at Google Scholar · View at Scopus
  88. J. F. Turrens, B. A. Freeman, J. G. Levitt, and J. D. Crapo, “The effect of hyperoxia on superoxide production by lung submitochondrial particles,” Archives of Biochemistry and Biophysics, vol. 217, no. 2, pp. 401–410, 1982. View at Publisher · View at Google Scholar · View at Scopus
  89. A. J. Lambert and M. D. Brand, “Superoxide production by NADH:ubiquinone oxidoreductase (complex I) depends on the pH gradient across the mitochondrial inner membrane,” Biochemical Journal, vol. 382, no. 2, pp. 511–517, 2004. View at Publisher · View at Google Scholar · View at Scopus
  90. A. J. Lambert and M. D. Brand, “Inhibitors of the quinone-binding site allow rapid superoxide production from mitochondrial NADH:ubiquinone oxidoreductase (complex I),” The Journal of Biological Chemistry, vol. 279, no. 38, pp. 39414–39420, 2004. View at Publisher · View at Google Scholar · View at Scopus
  91. J. R. Treberg, C. L. Quinlan, and M. D. Brand, “Evidence for two sites of superoxide production by mitochondrial NADH-ubiquinone oxidoreductase (complex I),” The Journal of Biological Chemistry, vol. 286, no. 31, pp. 27103–27110, 2011. View at Publisher · View at Google Scholar · View at Scopus
  92. Y.-R. Chen, C.-L. Chen, D. R. Pfeiffer, and J. L. Zweier, “Mitochondrial complex II in the post-ischemic heart: oxidative injury and the role of protein S-glutathionylation,” The Journal of Biological Chemistry, vol. 282, no. 45, pp. 32640–32654, 2007. View at Publisher · View at Google Scholar · View at Scopus
  93. R. G. Hansford, B. A. Hogue, and V. Mildaziene, “Dependence of H2O2 formation by rat heart mitochondria on substrate availability and donor age,” Journal of Bioenergetics and Biomembranes, vol. 29, no. 1, pp. 89–95, 1997. View at Publisher · View at Google Scholar · View at Scopus
  94. I. Siebels and S. Dröse, “Q-site inhibitor induced ROS production of mitochondrial complex II is attenuated by TCA cycle dicarboxylates,” Biochimica et Biophysica Acta (BBA)—Bioenergetics, vol. 1827, no. 10, pp. 1156–1164, 2013. View at Publisher · View at Google Scholar · View at Scopus
  95. Y.-R. Chen, C.-L. Chen, A. Yeh, X. Liu, and J. L. Zweier, “Direct and indirect roles of cytochrome b in the mediation of superoxide generation and NO catabolism by mitochondrial succinate-cytochrome c reductase,” The Journal of Biological Chemistry, vol. 281, no. 19, pp. 13159–13168, 2006. View at Publisher · View at Google Scholar · View at Scopus
  96. L. Zhang, L. Yu, and C.-A. Yu, “Generation of superoxide anion by succinate-cytochrome c reductase from bovine heart mitochondria,” Journal of Biological Chemistry, vol. 273, no. 51, pp. 33972–33976, 1998. View at Publisher · View at Google Scholar · View at Scopus
  97. T. V. Votyakova and I. J. Reynolds, “DeltaPsi(m)-dependent and -independent production of reactive oxygen species by rat brain mitochondria,” Journal of Neurochemistry, vol. 79, no. 2, pp. 266–277, 2001. View at Google Scholar
  98. C. L. Quinlan, A. L. Orr, I. V. Perevoshchikova, J. R. Treberg, B. A. Ackrell, and M. D. Brand, “Mitochondrial complex II can generate reactive oxygen species at high rates in both the forward and reverse reactions,” The Journal of Biological Chemistry, vol. 287, no. 32, pp. 27255–27264, 2012. View at Publisher · View at Google Scholar · View at Scopus
  99. J. Guo and B. D. Lemire, “The ubiquinone-binding site of the Saccharomyces cerevisiae succinate-ubiquinone oxidoreductase is a source of superoxide,” The Journal of Biological Chemistry, vol. 278, no. 48, pp. 47629–47635, 2003. View at Publisher · View at Google Scholar · View at Scopus
  100. V. Yankovskaya, R. Horsefield, S. Törnroth et al., “Architecture of succinate dehydrogenase and reactive oxygen species generation,” Science, vol. 299, no. 5607, pp. 700–704, 2003. View at Publisher · View at Google Scholar · View at Scopus
  101. A. Boveris, E. Cadenas, and A. O. M. Stoppani, “Role of ubiquinone in the mitochondrial generation of hydrogen peroxide,” Biochemical Journal, vol. 156, no. 2, pp. 435–444, 1976. View at Publisher · View at Google Scholar · View at Scopus
  102. E. Cadenas, A. Boveris, C. I. Ragan, and A. O. M. Stoppani, “Production of superoxide radicals and hydrogen peroxide by NADH-ubiquinone reductase and ubiquinol-cytochrome c reductase from beef-heart mitochondria,” Archives of Biochemistry and Biophysics, vol. 180, no. 2, pp. 248–257, 1977. View at Publisher · View at Google Scholar · View at Scopus
  103. J. F. Turrens, A. Alexandre, and A. L. Lehninger, “Ubisemiquinone is the electron donor for superoxide formation by complex III of heart mitochondria,” Archives of Biochemistry and Biophysics, vol. 237, no. 2, pp. 408–414, 1985. View at Publisher · View at Google Scholar · View at Scopus
  104. A. A. Starkov and G. Fiskum, “Myxothiazol induces H2O2 production from mitochondrial respiratory chain,” Biochemical and Biophysical Research Communications, vol. 281, no. 3, pp. 645–650, 2001. View at Publisher · View at Google Scholar · View at Scopus
  105. D. Han, E. Williams, and E. Cadenas, “Mitochondrial respiratory chain-dependent generation of superoxide anion and its release into the intermembrane space,” The Biochemical Journal, vol. 353, no. 2, pp. 411–416, 2001. View at Publisher · View at Google Scholar · View at Scopus
  106. F. L. Muller, Y. Liu, and H. Van Remmen, “Complex III releases superoxide to both sides of the inner mitochondrial membrane,” The Journal of Biological Chemistry, vol. 279, no. 47, pp. 49064–49073, 2004. View at Publisher · View at Google Scholar · View at Scopus
  107. J. L. Cape, M. K. Bowman, and D. M. Kramer, “A semiquinone intermediate generated at the Qo site of the cytochrome bc1 complex: importance for the Q-cycle and superoxide production,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 19, pp. 7887–7892, 2007. View at Publisher · View at Google Scholar · View at Scopus
  108. S. K. Prabu, H. K. Anandatheerthavarada, H. Raza, S. Srinivasan, J. F. Spear, and N. G. Avadhani, “Protein kinase A-mediated phosphorylation modulates cytochrome c oxidase function and augments hypoxia and myocardial ischemia-related injury,” The Journal of Biological Chemistry, vol. 281, no. 4, pp. 2061–2070, 2006. View at Publisher · View at Google Scholar · View at Scopus
  109. L. K. Kwong and R. S. Sohal, “Substrate and site specificity of hydrogen peroxide generation in mouse Mitochondria,” Archives of Biochemistry and Biophysics, vol. 350, no. 1, pp. 118–126, 1998. View at Publisher · View at Google Scholar · View at Scopus
  110. Z. Drahota, S. K. R. Chowdhury, D. Floryk et al., “Glycerophosphate-dependent hydrogen peroxide production by brown adipose tissue mitochondria and its activation by ferricyanide,” Journal of Bioenergetics and Biomembranes, vol. 34, no. 2, pp. 105–113, 2002. View at Publisher · View at Google Scholar · View at Scopus
  111. S. Miwa, J. St-Pierre, L. Partridge, and M. D. Brand, “Superoxide and hydrogen peroxide production by Drosophila mitochondria,” Free Radical Biology and Medicine, vol. 35, no. 8, pp. 938–948, 2003. View at Publisher · View at Google Scholar · View at Scopus
  112. H. J. Forman and J. Kennedy, “Dihydroorotate-dependent superoxide producton in rat brain and liver: a function of the primary dehydrogenase,” Archives of Biochemistry and Biophysics, vol. 173, no. 1, pp. 219–224, 1976. View at Publisher · View at Google Scholar · View at Scopus
  113. M. Hey-Mogensen, R. L. S. Goncalves, A. L. Orr, and M. D. Brand, “Production of superoxide/H2O2 by dihydroorotate dehydrogenase in rat skeletal muscle mitochondria,” Free Radical Biology and Medicine, vol. 72, pp. 149–155, 2014. View at Publisher · View at Google Scholar · View at Scopus
  114. M. Löffler, C. Becker, E. Wegerle, and G. Schuster, “Catalytic enzyme histochemistry and biochemical analysis of dihydroorotate dehydrogenase/oxidase and succinate dehydrogenase in mammalian tissues, cells and mitochondria,” Histochemistry and Cell Biology, vol. 105, no. 2, pp. 119–128, 1996. View at Publisher · View at Google Scholar · View at Scopus
  115. N. Hail, P. Chen, J. J. Kepa, L. R. Bushman, and C. Shearn, “Dihydroorotate dehydrogenase is required for N-(4-hydroxyphenyl)retinamide-induced reactive oxygen species production and apoptosis,” Free Radical Biology and Medicine, vol. 49, no. 1, pp. 109–116, 2010. View at Publisher · View at Google Scholar · View at Scopus
  116. M. Giorgio, E. Migliaccio, F. Orsini et al., “Electron transfer between cytochrome c and p66Shc generates reactive oxygen species that trigger mitochondrial apoptosis,” Cell, vol. 122, no. 2, pp. 221–233, 2005. View at Publisher · View at Google Scholar · View at Scopus
  117. G. G. Camici, M. Schiavoni, P. Francia et al., “Genetic deletion of p66Shc adaptor protein prevents hyperglycemia-induced endothelial dysfunction and oxidative stress,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 12, pp. 5217–5222, 2007. View at Publisher · View at Google Scholar · View at Scopus
  118. J. Vásquez-Vivar, B. Kalyanaraman, and M. C. Kennedy, “Mitochondrial aconitase is a source of hydroxyl radical. An electron spin resonance investigation,” The Journal of Biological Chemistry, vol. 275, no. 19, pp. 14064–14069, 2000. View at Publisher · View at Google Scholar · View at Scopus
  119. L. Tretter and V. Adam-Vizi, “Generation of reactive oxygen species in the reaction catalyzed by α-ketoglutarate dehydrogenase,” The Journal of Neuroscience, vol. 24, no. 36, pp. 7771–7778, 2004. View at Publisher · View at Google Scholar · View at Scopus
  120. A. A. Starkov, G. Fiskum, C. Chinopoulos et al., “Mitochondrial α-ketoglutarate dehydrogenase complex generates reactive oxygen species,” The Journal of Neuroscience, vol. 24, no. 36, pp. 7779–7788, 2004. View at Publisher · View at Google Scholar · View at Scopus
  121. S. A. Whatley, D. Curti, F. Das Gupta et al., “Superoxide, neuroleptics and the ubiquinone and cytochrome b5 reductases in brain and lymphocytes from normals and schizophrenic patients,” Molecular Psychiatry, vol. 3, no. 3, pp. 227–237, 1998. View at Publisher · View at Google Scholar · View at Scopus
  122. N. Hauptmann, J. Grimsby, J. C. Shih, and E. Cadenas, “The metabolism of tyramine by monoamine oxidase A/B causes oxidative damage to mitochondrial DNA,” Archives of Biochemistry and Biophysics, vol. 335, no. 2, pp. 295–304, 1996. View at Publisher · View at Google Scholar · View at Scopus
  123. A. Maurel, C. Hernandez, O. Kunduzova et al., “Age-dependent increase in hydrogen peroxide production by cardiac monoamine oxidase A in rats,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 284, no. 4, pp. H1460–H1467, 2003. View at Publisher · View at Google Scholar · View at Scopus
  124. F. Carvalho, J. A. Duarte, M. J. Neuparth et al., “Hydrogen peroxide production in mouse tissues after acute d-amphetamine administration. Influence of monoamine oxidase inhibition,” Archives of Toxicology, vol. 75, no. 8, pp. 465–469, 2001. View at Publisher · View at Google Scholar · View at Scopus
  125. C. Villeneuve, C. Guilbeau-Frugier, P. Sicard et al., “P53-PGC-1α pathway mediates oxidative mitochondrial damage and cardiomyocyte necrosis induced by monoamine oxidase-a upregulation: role in chronic left ventricular dysfunction in mice,” Antioxidants & Redox Signaling, vol. 18, no. 1, pp. 5–18, 2013. View at Publisher · View at Google Scholar · View at Scopus
  126. N. Kaludercic, A. Carpi, T. Nagayama et al., “Monoamine Oxidase B prompts mitochondrial and cardiac dysfunction in pressure overloaded hearts,” Antioxidants and Redox Signaling, vol. 20, no. 2, pp. 267–280, 2014. View at Publisher · View at Google Scholar · View at Scopus
  127. A. Sturza, M. S. Leisegang, A. Babelova et al., “Monoamine oxidases are mediators of endothelial dysfunction in the mouse aorta,” Hypertension, vol. 62, no. 1, pp. 140–146, 2013. View at Publisher · View at Google Scholar · View at Scopus
  128. A. Sturza, O. M. Duicu, A. Vaduva et al., “Monoamine oxidases are novel sources of cardiovascular oxidative stress in experimental diabetes,” Canadian Journal of Physiology and Pharmacology, vol. 93, no. 7, pp. 555–561, 2015. View at Publisher · View at Google Scholar · View at Scopus
  129. M. J. Kumar, D. G. Nicholls, and J. K. Andersen, “Oxidative α-ketoglutarate dehydrogenase inhibition via subtle elevations in monoamine oxidase B levels results in loss of spare respiratory capacity: implications for Parkinson's disease,” The Journal of Biological Chemistry, vol. 278, no. 47, pp. 46432–46439, 2003. View at Publisher · View at Google Scholar · View at Scopus
  130. E. J. Anderson, J. T. Efird, S. W. Davies et al., “Monoamine oxidase is a major determinant of redox balance in human atrial myocardium and is associated with postoperative atrial fibrillation,” Journal of the American Heart Association, vol. 3, no. 1, Article ID e000713, 2014. View at Publisher · View at Google Scholar · View at Scopus
  131. K.-U. Lee, I. K. Lee, J. Han et al., “Effects of recombinant adenovirus-mediated uncoupling protein 2 overexpression on endothelial function and apoptosis,” Circulation Research, vol. 96, no. 11, pp. 1200–1207, 2005. View at Publisher · View at Google Scholar · View at Scopus
  132. Y. Teshima, M. Akao, S. P. Jones, and E. Marbán, “Uncoupling protein-2 overexpression inhibits mitochondrial death pathway in cardiomyocytes,” Circulation Research, vol. 93, no. 3, pp. 192–200, 2003. View at Publisher · View at Google Scholar · View at Scopus
  133. F. Valsecchi, S. Grefte, P. Roestenberg et al., “Primary fibroblasts of NDUFS4-/- mice display increased ROS levels and aberrant mitochondrial morphology,” Mitochondrion, vol. 13, no. 5, pp. 436–443, 2013. View at Publisher · View at Google Scholar · View at Scopus
  134. L. Blanchet, S. Grefte, J. A. M. Smeitink, P. H. G. M. Willems, and W. J. H. Koopman, “Photo-induction and automated quantification of reversible mitochondrial permeability transition pore opening in primary mouse myotubes,” PLoS ONE, vol. 9, no. 11, Article ID e114090, 2014. View at Publisher · View at Google Scholar · View at Scopus
  135. C. Brenner and M. Moulin, “Physiological roles of the permeability transition pore,” Circulation Research, vol. 111, no. 9, pp. 1237–1247, 2012. View at Publisher · View at Google Scholar · View at Scopus
  136. F. Ichas and J.-P. Mazat, “From calcium signaling to cell death: two conformations for the mitochondrial permeability transition pore. Switching from low- to high-conductance state,” Biochimica et Biophysica Acta, vol. 1366, no. 1-2, pp. 33–50, 1998. View at Publisher · View at Google Scholar · View at Scopus
  137. L. Sun, S. Shukair, T. J. Naik, F. Moazed, and H. Ardehali, “Glucose phosphorylation and mitochondrial binding are required for the protective effects of hexokinases I and II,” Molecular and Cellular Biology, vol. 28, no. 3, pp. 1007–1017, 2008. View at Publisher · View at Google Scholar · View at Scopus
  138. C.-L. Chen, J. Chen, S. Rawale et al., “Protein tyrosine nitration of the flavin subunit is associated with oxidative modification of mitochondrial complex II in the post-ischemic myocardium,” Journal of Biological Chemistry, vol. 283, no. 41, pp. 27991–28003, 2008. View at Publisher · View at Google Scholar · View at Scopus
  139. J. Garcia, D. Han, H. Sancheti, L.-P. Yap, N. Kaplowitz, and E. Cadenas, “Regulation of mitochondrial glutathione redox status and protein glutathionylation by respiratory substrates,” Journal of Biological Chemistry, vol. 285, no. 51, pp. 39646–39654, 2010. View at Publisher · View at Google Scholar · View at Scopus
  140. S. M. Beer, E. R. Taylor, S. E. Brown et al., “Glutaredoxin 2 catalyzes the reversible oxidation and glutathionylation of mitochondrial membrane thiol proteins: implications for mitochondrial redox regulation and antioxidant defense,” Journal of Biological Chemistry, vol. 279, no. 46, pp. 47939–47951, 2004. View at Publisher · View at Google Scholar · View at Scopus
  141. T. R. Hurd, R. Requejo, A. Filipovska et al., “Complex I within oxidatively stressed bovine heart mitochondria is glutathionylated on Cys-531 and Cys-704 of the 75-kDa subunit: potential role of Cys residues in decreasing oxidative damage,” The Journal of Biological Chemistry, vol. 283, no. 36, pp. 24801–24815, 2008. View at Publisher · View at Google Scholar · View at Scopus
  142. E. R. Taylor, F. Hurrell, R. J. Shannon, T.-K. Lin, J. Hirst, and M. P. Murphy, “Reversible glutathionylation of complex I increases mitochondrial superoxide formation,” Journal of Biological Chemistry, vol. 278, no. 22, pp. 19603–19610, 2003. View at Publisher · View at Google Scholar · View at Scopus
  143. D. C. Liemburg-Apers, P. H. G. M. Willems, W. J. H. Koopman, and S. Grefte, “Interactions between mitochondrial reactive oxygen species and cellular glucose metabolism,” Archives of Toxicology, vol. 89, no. 8, pp. 1209–1226, 2015. View at Publisher · View at Google Scholar · View at Scopus
  144. K. A. Brand and U. Hermfisse, “Aerobic glycolysis by proliferating cells: a protective strategy against reactive oxygen species,” The FASEB Journal, vol. 11, no. 5, pp. 388–395, 1997. View at Google Scholar · View at Scopus
  145. G. Debska, A. Kicinska, J. Skalska et al., “Opening of potassium channels modulates mitochondrial function in rat skeletal muscle,” Biochimica et Biophysica Acta, vol. 1556, no. 2-3, pp. 97–105, 2002. View at Publisher · View at Google Scholar · View at Scopus
  146. A. Petruş, O. M. Duicu, A. Sturza et al., “Modulation of mitochondrial respiratory function and ROS production by novel benzopyran analogues,” Canadian Journal of Physiology and Pharmacology, vol. 93, no. 9, pp. 811–818, 2015. View at Publisher · View at Google Scholar · View at Scopus
  147. P. P. Dzeja, P. Bast, C. Ozcan et al., “Targeting nucleotide-requiring enzymes: implications for diazoxide-induced cardioprotection,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 284, no. 4, pp. H1048–H1056, 2003. View at Publisher · View at Google Scholar · View at Scopus
  148. T. R. Cung, O. Morel, G. Cayla et al., “Cyclosporine before PCI in patients with acute myocardial infarction,” The New England Journal of Medicine, vol. 373, no. 11, pp. 1021–1031, 2015. View at Publisher · View at Google Scholar
  149. D. Atar, H. Arheden, A. Berdeaux et al., “Effect of intravenous TRO40303 as an adjunct to primary percutaneous coronary intervention for acute ST-elevation myocardial infarction: MITOCARE study results,” European Heart Journal, vol. 36, no. 2, pp. 112–119, 2015. View at Publisher · View at Google Scholar · View at Scopus
  150. C. M. Gibson, R. P. Giugliano, R. A. Kloner et al., “EMBRACE STEMI study: a phase 2a trial to evaluate the safety, tolerability, and efficacy of intravenous MTP-131 on reperfusion injury in patients undergoing primary percutaneous coronary intervention,” European Heart Journal, 2015. View at Publisher · View at Google Scholar
  151. D. A. Jones, C. Pellaton, S. Velmurugan et al., “Randomized phase 2 trial of intracoronary nitrite during acute myocardial infarction,” Circulation Research, vol. 116, no. 3, pp. 437–447, 2015. View at Publisher · View at Google Scholar · View at Scopus
  152. N. Siddiqi, C. Neil, M. Bruce et al., “Intravenous sodium nitrite in acute ST-elevation myocardial infarction: a randomized controlled trial (NIAMI),” European Heart Journal, vol. 35, no. 19, pp. 1255–1262, 2014. View at Publisher · View at Google Scholar · View at Scopus
  153. M. Forkink, F. Basit, J. Teixeira, H. G. Swarts, W. J. H. Koopman, and P. H. G. M. Willems, “Complex I and complex III inhibition specifically increase cytosolic hydrogen peroxide levels without inducing oxidative stress in HEK293 cells,” Redox Biology, vol. 6, pp. 607–616, 2015. View at Publisher · View at Google Scholar · View at Scopus
  154. J. R. Burgoyne, H. Mongue-Din, P. Eaton, and A. M. Shah, “Redox signaling in cardiac physiology and pathology,” Circulation Research, vol. 111, no. 8, pp. 1091–1106, 2012. View at Publisher · View at Google Scholar · View at Scopus
  155. S. F. Steinberg, “Oxidative stress and sarcomeric proteins,” Circulation Research, vol. 112, no. 2, pp. 393–405, 2013. View at Publisher · View at Google Scholar
  156. D. B. Zorov, C. R. Filburn, L.-O. Klotz, J. L. Zweier, and S. J. Sollott, “Reactive oxygen species (ROS)-induced ROS release: a new phenomenon accompanying induction of the mitochondrial permeability transition in cardiac myocytes,” The Journal of Experimental Medicine, vol. 192, no. 7, pp. 1001–1014, 2000. View at Publisher · View at Google Scholar · View at Scopus
  157. A. Daiber, “Redox signaling (cross-talk) from and to mitochondria involves mitochondrial pores and reactive oxygen species,” Biochimica et Biophysica Acta (BBA)—Bioenergetics, vol. 1797, no. 6-7, pp. 897–906, 2010. View at Publisher · View at Google Scholar · View at Scopus
  158. S. Karbach, P. Wenzel, A. Waisman, T. Münzel, and A. Daiber, “eNOS uncoupling in cardiovascular diseases-the role of oxidative stress and inflammation,” Current Pharmaceutical Design, vol. 20, no. 22, pp. 3579–3594, 2014. View at Publisher · View at Google Scholar · View at Scopus
  159. J.-M. Li and A. M. Shah, “Endothelial cell superoxide generation: regulation and relevance for cardiovascular pathophysiology,” American Journal of Physiology—Regulatory Integrative and Comparative Physiology, vol. 287, no. 5, pp. R1014–R1030, 2004. View at Publisher · View at Google Scholar · View at Scopus
  160. Y. Liu, H. Zhao, H. Li, B. Kalyanaraman, A. C. Nicolosi, and D. D. Gutterman, “Mitochondrial sources of H2O2 generation play a key role in flow-mediated dilation in human coronary resistance arteries,” Circulation Research, vol. 93, no. 6, pp. 573–580, 2003. View at Publisher · View at Google Scholar · View at Scopus
  161. D. X. Zhang, L. Borbouse, D. Gebremedhin et al., “H2O2-induced dilation in human coronary arterioles: role of protein kinase G dimerization and large-conductance Ca2+-activated K+ channel activation,” Circulation Research, vol. 110, no. 3, pp. 471–480, 2012. View at Publisher · View at Google Scholar · View at Scopus
  162. Y. F. Pung, W. J. Sam, K. Stevanov et al., “Mitochondrial oxidative stress corrupts coronary collateral growth by activating adenosine monophosphate activated kinase-α signaling,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 33, no. 8, pp. 1911–1919, 2013. View at Publisher · View at Google Scholar · View at Scopus
  163. S.-I. Saitoh, T. Kiyooka, P. Rocic et al., “Redox-dependent coronary metabolic dilation,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 293, no. 6, pp. H3720–H3725, 2007. View at Publisher · View at Google Scholar · View at Scopus
  164. P. A. Rogers, W. M. Chilian, I. N. Bratz, R. M. Bryan Jr., and G. M. Dick, “H2O2 activates redox- and 4-aminopyridine-sensitive Kv channels in coronary vascular smooth muscle,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 292, no. 3, pp. H1404–H1411, 2007. View at Publisher · View at Google Scholar · View at Scopus
  165. R. D. Guzy and P. T. Schumacker, “Oxygen sensing by mitochondria at complex III: the paradox of increased reactive oxygen species during hypoxia,” Experimental Physiology, vol. 91, no. 5, pp. 807–819, 2006. View at Publisher · View at Google Scholar · View at Scopus
  166. B. Liu, A. K. Tewari, L. Zhang et al., “Proteomic analysis of protein tyrosine nitration after ischemia reperfusion injury: mitochondria as the major target,” Biochimica et Biophysica Acta—Proteins and Proteomics, vol. 1794, no. 3, pp. 476–485, 2009. View at Publisher · View at Google Scholar · View at Scopus
  167. J. F. Spear, S. K. Prabu, D. Galati, H. Raza, H. K. Anandatheerthavarada, and N. G. Avadhani, “β1-Adrenoreceptor activation contributes to ischemia-reperfusion damage as well as playing a role in ischemic preconditioning,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 292, no. 5, pp. H2459–H2466, 2007. View at Publisher · View at Google Scholar · View at Scopus
  168. H.-L. Lee, C.-L. Chen, S. T. Yeh, J. L. Zweier, and Y.-R. Chen, “Biphasic modulation of the mitochondrial electron transport chain in myocardial ischemia and reperfusion,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 302, no. 7, pp. H1410–H1422, 2012. View at Publisher · View at Google Scholar · View at Scopus
  169. G. Paradies, G. Petrosillo, M. Pistolese, N. Di Venosa, A. Federici, and F. M. Ruggiero, “Decrease in mitochondrial complex I activity in ischemic/reperfused rat heart: involvement of reactive oxygen species and cardiolipin,” Circulation Research, vol. 94, no. 1, pp. 53–59, 2004. View at Publisher · View at Google Scholar · View at Scopus
  170. A. K. Gadicherla, D. F. Stowe, W. E. Antholine, M. Yang, and A. K. S. Camara, “Damage to mitochondrial complex i during cardiac ischemia reperfusion injury is reduced indirectly by anti-anginal drug ranolazine,” Biochimica et Biophysica Acta (BBA)—Bioenergetics, vol. 1817, no. 3, pp. 419–429, 2012. View at Publisher · View at Google Scholar · View at Scopus
  171. J. L. Zweier, J. T. Flaherty, and M. L. Weisfeldt, “Direct measurement of free radical generation following reperfusion of ischemic myocardium,” Proceedings of the National Academy of Sciences of the United States of America, vol. 84, no. 5, pp. 1404–1407, 1987. View at Publisher · View at Google Scholar · View at Scopus
  172. G. Petrosillo, F. M. Ruggiero, N. Di Venosa, and G. Paradies, “Decreased complex III activity in mitochondria isolated from rat heart subjected to ischemia and reperfusion: role of reactive oxygen species and cardiolipin,” The FASEB Journal, vol. 17, no. 6, pp. 714–716, 2003. View at Google Scholar · View at Scopus
  173. S. Dröse, P. J. Hanley, and U. Brandt, “Ambivalent effects of diazoxide on mitochondrial ROS production at respiratory chain complexes I and III,” Biochimica et Biophysica Acta (BBA)—General Subjects, vol. 1790, no. 6, pp. 558–565, 2009. View at Publisher · View at Google Scholar · View at Scopus
  174. P. Bianchi, O. Kunduzova, E. Masini et al., “Oxidative stress by monoamine oxidase mediates receptor-independent cardiomyocyte apoptosis by serotonin and postischemic myocardial injury,” Circulation, vol. 112, no. 21, pp. 3297–3305, 2005. View at Publisher · View at Google Scholar · View at Scopus
  175. N. Kaludercic, A. Carpi, R. Menabò, F. Di Lisa, and N. Paolocci, “Monoamine oxidases (MAO) in the pathogenesis of heart failure and ischemia/reperfusion injury,” Biochimica et Biophysica Acta, vol. 1813, no. 7, pp. 1323–1332, 2011. View at Publisher · View at Google Scholar · View at Scopus
  176. P. Bianchi, D. R. Pimentel, M. P. Murphy, W. S. Colucci, and A. Parini, “A new hypertrophic mechanism of serotonin in cardiac myocytes: receptor-independent ROS generation,” The FASEB Journal, vol. 19, no. 6, pp. 641–643, 2005. View at Publisher · View at Google Scholar · View at Scopus
  177. A. Carpi, R. Menabò, N. Kaludercic, P. Pelicci, F. Di Lisa, and M. Giorgio, “The cardioprotective effects elicited by p66Shc ablation demonstrate the crucial role of mitochondrial ROS formation in ischemia/reperfusion injury,” Biochimica et Biophysica Acta, vol. 1787, no. 7, pp. 774–780, 2009. View at Publisher · View at Google Scholar · View at Scopus
  178. N. Kaludercic, E. Takimoto, T. Nagayama et al., “Monoamine oxidase a-mediated enhanced catabolism of norepinephrine contributes to adverse remodeling and pump failure in hearts with pressure overload,” Circulation Research, vol. 106, no. 1, pp. 193–202, 2010. View at Publisher · View at Google Scholar · View at Scopus
  179. S. D. Sivasubramaniam, C. C. Finch, M. J. Rodriguez, N. Mahy, and E. E. Billett, “A comparative study of the expression of monoamine oxidase-A and -B mRNA and protein in non-CNS human tissues,” Cell and Tissue Research, vol. 313, no. 3, pp. 291–300, 2003. View at Publisher · View at Google Scholar · View at Scopus
  180. R. Vogel, H. Wiesinger, B. Hamprecht, and R. Dringen, “The regeneration of reduced glutathione in rat forebrain mitochondria identifies metabolic pathways providing the NADPH required,” Neuroscience Letters, vol. 275, no. 2, pp. 97–100, 1999. View at Publisher · View at Google Scholar · View at Scopus
  181. I. Andreadou, E. K. Iliodromitis, D. Farmakis, and D. T. Kremastinos, “To prevent, protect and save the ischemic heart: antioxidants revisited,” Expert Opinion on Therapeutic Targets, vol. 13, no. 8, pp. 945–956, 2009. View at Publisher · View at Google Scholar · View at Scopus
  182. P. M. W. Bath, L. J. Gray, A. J. G. Bath, A. Buchan, T. Miyata, and A. R. Green, “Effects of NXY-059 in experimental stroke: an individual animal meta-analysis,” British Journal of Pharmacology, vol. 157, no. 7, pp. 1157–1171, 2009. View at Publisher · View at Google Scholar · View at Scopus
  183. T. Jaxa-Chamiec, B. Bednarz, K. Herbaczynska-Cedro, P. Maciejewski, and L. Ceremuzynski, “Effects of vitamins C and E on the outcome after acute myocardial infarction in diabetics: a retrospective, hypothesis-generating analysis from the MIVIT Study,” Cardiology, vol. 112, no. 3, pp. 219–223, 2009. View at Publisher · View at Google Scholar · View at Scopus
  184. D. P. Vivekananthan, M. S. Penn, S. K. Sapp, A. Hsu, and E. J. Topol, “Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials,” The Lancet, vol. 361, no. 9374, pp. 2017–2023, 2003. View at Publisher · View at Google Scholar · View at Scopus
  185. S. R. Steinhubl, “Why have antioxidants failed in clinical trials?” The American Journal of Cardiology A, vol. 101, no. 10, pp. S14–S19, 2008. View at Publisher · View at Google Scholar · View at Scopus
  186. A. Dhanasekaran, S. Kotamraju, S. V. Kalivendi et al., “Supplementation of endothelial cells with mitochondria-targeted antioxidants inhibit peroxide-induced mitochondrial iron uptake, oxidative damage, and apoptosis,” The Journal of Biological Chemistry, vol. 279, no. 36, pp. 37575–37587, 2004. View at Publisher · View at Google Scholar · View at Scopus
  187. M. V. Covey, M. P. Murphy, C. E. Hobbs, R. A. J. Smith, and D. E. Oorschot, “Effect of the mitochondrial antioxidant, Mito Vitamin E, on hypoxic-ischemic striatal injury in neonatal rats: a dose-response and stereological study,” Experimental Neurology, vol. 199, no. 2, pp. 513–519, 2006. View at Publisher · View at Google Scholar · View at Scopus
  188. S. M. Davidson and M. R. Duchen, “Endothelial mitochondria: contributing to vascular function and disease,” Circulation Research, vol. 100, no. 8, pp. 1128–1141, 2007. View at Publisher · View at Google Scholar · View at Scopus
  189. V. J. Adlam, J. C. Harrison, C. M. Porteous et al., “Targeting an antioxidant to mitochondria decreases cardiac ischemia-reperfusion injury,” The FASEB Journal, vol. 19, no. 9, pp. 1088–1095, 2005. View at Publisher · View at Google Scholar · View at Scopus
  190. L. E. Bakeeva, I. V. Barskov, M. V. Egorov et al., “Mitochondria-targeted plastoquinone derivatives as tools to interrupt execution of the aging program. 2. Treatment of some ROS- and age-related diseases (heart arrhythmia, heart infarctions, kidney ischemia, and stroke),” Biochemistry, vol. 73, no. 12, pp. 1288–1299, 2008. View at Publisher · View at Google Scholar · View at Scopus
  191. J. Navarro-Yepes, L. Zavala-Flores, A. Anandhan et al., “Antioxidant gene therapy against neuronal cell death,” Pharmacology and Therapeutics, vol. 142, no. 2, pp. 206–230, 2014. View at Publisher · View at Google Scholar · View at Scopus
  192. Y.-B. Ouyang, C. M. Stary, R. E. White, and R. G. Giffard, “The use of microRNAs to modulate redox and immune response to stroke,” Antioxidants & Redox Signaling, vol. 22, no. 2, pp. 187–202, 2015. View at Publisher · View at Google Scholar · View at Scopus
  193. D. J. Hearse, S. M. Humphrey, and E. B. Chain, “Abrupt reoxygenation of the anoxic potassium-arrested perfused rat heart: a study of myocardial enzyme release,” Journal of Molecular and Cellular Cardiology, vol. 5, no. 4, pp. 395–407, 1973. View at Publisher · View at Google Scholar · View at Scopus
  194. K. A. Reimer, C. E. Murry, and V. J. Richard, “The role of neutrophils and free radicals in the ischemic-reperfused heart: why the confusion and controversy?” Journal of Molecular and Cellular Cardiology, vol. 21, no. 12, pp. 1225–1239, 1989. View at Publisher · View at Google Scholar · View at Scopus
  195. C. E. Murry, R. B. Jennings, and K. A. Reimer, “Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium,” Circulation, vol. 74, no. 5, pp. 1124–1136, 1986. View at Publisher · View at Google Scholar · View at Scopus
  196. Z. Q. Zhao, J. S. Corvera, M. E. Halkos et al., “Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning,” American Journal of Physiology Heart and Circulatory Physiology, vol. 285, no. 2, pp. H579–H588, 2003. View at Publisher · View at Google Scholar
  197. G. Heusch, “Postconditioning: old wine in a new bottle?” Journal of the American College of Cardiology, vol. 44, no. 5, pp. 1111–1112, 2004. View at Publisher · View at Google Scholar · View at Scopus
  198. S. Y. Lim and D. J. Hausenloy, “Remote ischemic conditioning: from bench to bedside,” Frontiers in Physiology, vol. 3, article 27, 2012. View at Publisher · View at Google Scholar
  199. M. V. Cohen and J. M. Downey, “Signalling pathways and mechanisms of protection in pre- and postconditioning: historical perspective and lessons for the future,” British Journal of Pharmacology, vol. 172, no. 8, pp. 1913–1932, 2015. View at Publisher · View at Google Scholar · View at Scopus
  200. G. Heusch, “Molecular basis of cardioprotection: signal transduction in ischemic pre-, post-, and remote conditioning,” Circulation Research, vol. 116, no. 4, pp. 674–699, 2015. View at Publisher · View at Google Scholar · View at Scopus
  201. T. L. Vanden Hoek, L. B. Becker, Z. Shao, C. Li, and P. T. Schumacker, “Reactive oxygen species released from mitochondria during brief hypoxia induce preconditioning in cardiomyocytes,” The Journal of Biological Chemistry, vol. 273, no. 29, pp. 18092–18098, 1998. View at Publisher · View at Google Scholar · View at Scopus
  202. R. Quarrie, B. M. Cramer, D. S. Lee et al., “Ischemic preconditioning decreases mitochondrial proton leak and reactive oxygen species production in the postischemic heart,” Journal of Surgical Research, vol. 165, no. 1, pp. 5–14, 2011. View at Publisher · View at Google Scholar · View at Scopus
  203. I. Tritto, D. D'Andrea, N. Eramo et al., “Oxygen radicals can induce preconditioning in rabbit hearts,” Circulation Research, vol. 80, no. 5, pp. 743–748, 1997. View at Publisher · View at Google Scholar · View at Scopus
  204. W. Chen, S. Gabel, C. Steenbergen, and E. Murphy, “A redox-based mechanism for cardioprotection induced by ischemic preconditioning in perfused rat heart,” Circulation Research, vol. 77, no. 2, pp. 424–429, 1995. View at Publisher · View at Google Scholar · View at Scopus
  205. R. A. Forbes, C. Steenbergen, and E. Murphy, “Diazoxide-induced cardioprotection requires signaling through a redox-sensitive mechanism,” Circulation Research, vol. 88, no. 8, pp. 802–809, 2001. View at Publisher · View at Google Scholar · View at Scopus
  206. H. Otani, “Reactive oxygen species as mediators of signal transduction in ischemic preconditioning,” Antioxidants and Redox Signaling, vol. 6, no. 2, pp. 449–469, 2004. View at Publisher · View at Google Scholar · View at Scopus
  207. A. D. T. Costa, R. Jakob, C. L. Costa, K. Andrukhiv, I. C. West, and K. D. Garlid, “The mechanism by which the mitochondrial ATP-sensitive K+ channel opening and H2O2 inhibit the mitochondrial permeability transition,” The Journal of Biological Chemistry, vol. 281, no. 30, pp. 20801–20808, 2006. View at Publisher · View at Google Scholar · View at Scopus
  208. E. Murphy and C. Steenbergen, “Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury,” Physiological Reviews, vol. 88, no. 2, pp. 581–609, 2008. View at Publisher · View at Google Scholar · View at Scopus
  209. V. Petronilli, D. Penzo, L. Scorrano, P. Bernardi, and F. Di Lisa, “The mitochondrial permeability transition, release of cytochrome c and cell death. Correlation with the duration of pore openings in situ,” The Journal of Biological Chemistry, vol. 276, no. 15, pp. 12030–12034, 2001. View at Publisher · View at Google Scholar · View at Scopus
  210. D. J. Hausenloy, S. Y. Lim, S.-G. Ong, S. M. Davidson, and D. M. Yellon, “Mitochondrial cyclophilin-D as a critical mediator of ischaemic preconditioning,” Cardiovascular Research, vol. 88, no. 1, pp. 67–74, 2010. View at Publisher · View at Google Scholar · View at Scopus
  211. N. Yamashita, S. Hoshida, N. Taniguchi, T. Kuzuya, and M. Hori, “Whole-body hyperthermia provides biphasic cardioprotection against Ischemia/reperfusion injury in the rat,” Circulation, vol. 98, no. 14, pp. 1414–1421, 1998. View at Publisher · View at Google Scholar · View at Scopus
  212. Y. Yaguchi, H. Satoh, N. Wakahara et al., “Protective effects of hydrogen peroxide against ischemia/reperfusion injury in perfused rat hearts,” Circulation Journal, vol. 67, no. 3, pp. 253–258, 2003. View at Publisher · View at Google Scholar · View at Scopus
  213. C. Penna, D. Mancardi, R. Rastaldo, and P. Pagliaro, “Cardioprotection: a radical view: free radicals in pre and postconditioning,” Biochimica et Biophysica Acta (BBA)—Bioenergetics, vol. 1787, no. 7, pp. 781–793, 2009. View at Publisher · View at Google Scholar · View at Scopus
  214. M. D. Dănilă, A. I. Privistirescu, S. N. Mirica et al., “Acute inhibition of monoamine oxidase and ischemic preconditioning in isolated rat hearts: interference with postischemic functional recovery but no effect on infarct size reduction,” Canadian Journal of Physiology and Pharmacology, vol. 93, no. 9, pp. 819–825, 2015. View at Publisher · View at Google Scholar · View at Scopus
  215. C. Penna, R. Rastaldo, D. Mancardi et al., “Post-conditioning induced cardioprotection requires signaling through a redox-sensitive mechanism, mitochondrial ATP-sensitive K+ channel and protein kinase C activation,” Basic Research in Cardiology, vol. 101, no. 2, pp. 180–189, 2006. View at Publisher · View at Google Scholar · View at Scopus
  216. Y. M. Tsutsumi, T. Yokoyama, Y. Horikawa, D. M. Roth, and H. H. Patel, “Reactive oxygen species trigger ischemic and pharmacological postconditioning: In vivo and in vitro characterization,” Life Sciences, vol. 81, no. 15, pp. 1223–1227, 2007. View at Publisher · View at Google Scholar · View at Scopus
  217. P. Sörensson, N. Saleh, F. Bouvier et al., “Effect of postconditioning on infarct size in patients with ST elevation myocardial infarction,” Heart, vol. 96, no. 21, pp. 1710–1715, 2010. View at Publisher · View at Google Scholar · View at Scopus
  218. F. Thuny, O. Lairez, F. Roubille et al., “Post-conditioning reduces infarct size and edema in patients with ST-segment elevation myocardial infarction,” Journal of the American College of Cardiology, vol. 59, no. 24, pp. 2175–2181, 2012. View at Publisher · View at Google Scholar · View at Scopus
  219. X. Freixa, N. Bellera, J. T. Ortiz-Pérez et al., “Ischaemic postconditioning revisited: lack of effects on infarct size following primary percutaneous coronary intervention,” European Heart Journal, vol. 33, no. 1, pp. 103–112, 2012. View at Publisher · View at Google Scholar · View at Scopus
  220. J.-Y. Hahn, Y. B. Song, E. K. Kim et al., “Ischemic postconditioning during primary percutaneous coronary intervention: the effects of postconditioning on myocardial reperfusion in patients with st-segment elevation myocardial infarction (POST) randomized trial,” Circulation, vol. 128, no. 17, pp. 1889–1896, 2013. View at Publisher · View at Google Scholar · View at Scopus
  221. J. T. Lønborg, “Targeting reperfusion injury in the era of primary percutaneous coronary intervention: hope or hype?” Heart, vol. 101, no. 20, pp. 1612–1618, 2015. View at Publisher · View at Google Scholar · View at Scopus
  222. K. Przyklenk, B. Bauer, M. Ovize, R. A. Kloner, and P. Whittaker, “Regional ischemic ‘preconditioning’ protects remote virgin myocardium from subsequent sustained coronary occlusion,” Circulation, vol. 87, no. 3, pp. 893–899, 1993. View at Publisher · View at Google Scholar · View at Scopus
  223. D. J. Hausenloy and D. M. Yellon, “Remote ischaemic preconditioning: underlying mechanisms and clinical application,” Cardiovascular Research, vol. 79, no. 3, pp. 377–386, 2008. View at Publisher · View at Google Scholar · View at Scopus
  224. C. Weinbrenner, F. Schulze, L. Sárváry, and R. H. Strasser, “Remote preconditioning by infrarenal aortic occlusion is operative via δ1-opioid receptors and free radicals in vivo in the rat heart,” Cardiovascular Research, vol. 61, no. 3, pp. 591–599, 2004. View at Publisher · View at Google Scholar · View at Scopus
  225. T. Rassaf, M. Totzeck, U. B. Hendgen-Cotta, S. Shiva, G. Heusch, and M. Kelm, “Circulating nitrite contributes to cardioprotection by remote ischemic preconditioning,” Circulation Research, vol. 114, no. 10, pp. 1601–1610, 2014. View at Publisher · View at Google Scholar · View at Scopus
  226. P. Dromparis and E. D. Michelakis, “Mitochondria in vascular health and disease,” Annual Review of Physiology, vol. 75, pp. 95–126, 2013. View at Publisher · View at Google Scholar · View at Scopus
  227. M. A. Kluge, J. L. Fetterman, and J. A. Vita, “Mitochondria and endothelial function,” Circulation Research, vol. 112, no. 8, pp. 1171–1188, 2013. View at Publisher · View at Google Scholar
  228. O. Culic, M. L. H. Gruwel, and J. Schrader, “Energy turnover of vascular endothelial cells,” American Journal of Physiology-Cell Physiology, vol. 273, no. 1, part 1, pp. C205–C213, 1997. View at Google Scholar · View at Scopus
  229. Y. Liu, H. Li, A. H. Bubolz, D. X. Zhang, and D. D. Gutterman, “Endothelial cytoskeletal elements are critical for flow-mediated dilation in human coronary arterioles,” Medical & Biological Engineering & Computing, vol. 46, no. 5, pp. 469–478, 2008. View at Publisher · View at Google Scholar · View at Scopus
  230. A.-B. Al-Mehdi, V. M. Pastukh, B. M. Swiger et al., “Perinuclear mitochondrial clustering creates an oxidant-rich nuclear domain required for hypoxia-induced transcription,” Science Signaling, vol. 5, no. 231, article ra47, 2012. View at Publisher · View at Google Scholar · View at Scopus
  231. S.-B. Ong, S. Subrayan, S. Y. Lim, D. M. Yellon, S. M. Davidson, and D. J. Hausenloy, “Inhibiting mitochondrial fission protects the heart against ischemia/reperfusion injury,” Circulation, vol. 121, no. 18, pp. 2012–2022, 2010. View at Publisher · View at Google Scholar · View at Scopus
  232. S. M. Shenouda, M. E. Widlansky, K. Chen et al., “Altered mitochondrial dynamics contributes to endothelial dysfunction in diabetes mellitus,” Circulation, vol. 124, no. 4, pp. 444–453, 2011. View at Publisher · View at Google Scholar
  233. X. Tang, Y. X. Luo, H. Z. Chen, and D. P. Liu, “Mitochondria, endothelial cell function, and vascular diseases,” Frontiers in Physiology, vol. 5, article 175, 2014. View at Publisher · View at Google Scholar
  234. M. F. Algahim, S. Sen, and H. Taegtmeyer, “Bariatric surgery to unload the stressed heart: a metabolic hypothesis,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 302, no. 8, pp. H1539–H1545, 2012. View at Publisher · View at Google Scholar · View at Scopus
  235. B. G. Hill, G. A. Benavides, J. J. R. Lancaster Jr. et al., “Integration of cellular bioenergetics with mitochondrial quality control and autophagy,” Biological Chemistry, vol. 393, no. 12, pp. 1485–1512, 2012. View at Publisher · View at Google Scholar · View at Scopus
  236. S. W. Ballinger, C. Patterson, C.-N. Yan et al., “Hydrogen peroxide- and peroxynitrite-induced mitochondrial DNA damage and dysfunction in vascular endothelial and smooth muscle cells,” Circulation Research, vol. 86, no. 9, pp. 960–966, 2000. View at Publisher · View at Google Scholar · View at Scopus
  237. F. Chen, S. Haigh, S. Barman, and D. J. Fulton, “From form to function: the role of Nox4 in the cardiovascular system,” Frontiers in Physiology, vol. 3, article 412, 2012. View at Publisher · View at Google Scholar
  238. B. Lassegue, A. San Martin, and K. K. Griendling, “Biochemistry, physiology, and pathophysiology of NADPH oxidases in the cardiovascular system,” Circulation Research, vol. 110, no. 10, pp. 1364–1390, 2012. View at Publisher · View at Google Scholar
  239. S. I. Dikalov, A. E. Dikalova, A. T. Bikineyeva, H. H. H. W. Schmidt, D. G. Harrison, and K. K. Griendling, “Distinct roles of Nox1 and Nox4 in basal and angiotensin II-stimulated superoxide and hydrogen peroxide production,” Free Radical Biology & Medicine, vol. 45, no. 9, pp. 1340–1351, 2008. View at Publisher · View at Google Scholar · View at Scopus
  240. K. Schröder, M. Zhang, S. Benkhoff et al., “Nox4 is a protective reactive oxygen species generating vascular NADPH oxidase,” Circulation Research, vol. 110, no. 9, pp. 1217–1225, 2012. View at Publisher · View at Google Scholar · View at Scopus
  241. R. P. Brandes, I. Takac, and K. Schröder, “No superoxide-no stress?: Nox4, the good NADPH oxidase!,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 31, no. 6, pp. 1255–1257, 2011. View at Publisher · View at Google Scholar · View at Scopus
  242. F. Veit, O. Pak, B. Egemnazarov et al., “Function of NADPH oxidase 1 in pulmonary arterial smooth muscle cells after monocrotaline-induced pulmonary vascular remodeling,” Antioxidants & Redox Signaling, vol. 19, no. 18, pp. 2213–2231, 2013. View at Publisher · View at Google Scholar · View at Scopus
  243. F. J. Sánchez-Gómez, E. Calvo, R. Bretón-Romero et al., “NOX4-dependent Hydrogen peroxide promotes shear stress-induced SHP2 sulfenylation and eNOS activation,” Free Radical Biology & Medicine, vol. 89, pp. 419–430, 2015. View at Publisher · View at Google Scholar · View at Scopus
  244. C. Schürmann, F. Rezende, C. Kruse et al., “The NADPH oxidase Nox4 has anti-atherosclerotic functions,” European Heart Journal, vol. 36, no. 48, pp. 3447–3456, 2015. View at Publisher · View at Google Scholar
  245. F. Paneni, P. Mocharla, A. Akhmedov et al., “Gene silencing of the mitochondrial adaptor p66(Shc) suppresses vascular hyperglycemic memory in diabetes,” Circulation Research, vol. 111, no. 3, pp. 278–289, 2012. View at Publisher · View at Google Scholar · View at Scopus
  246. C. Napoli, I. Martin-Padura, F. De Nigris et al., “Deletion of the p66Shc longevity gene reduces systemic and tissue oxidative stress, vascular cell apoptosis, and early atherogenesis in mice fed a high-fat diet,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 4, pp. 2112–2116, 2003. View at Publisher · View at Google Scholar · View at Scopus
  247. J. Feng and Z. Zuo, “Isoflurane preconditioning increases endothelial cell tolerance to in-vitro simulated ischaemia,” Journal of Pharmacy and Pharmacology, vol. 63, no. 1, pp. 106–110, 2011. View at Publisher · View at Google Scholar
  248. A. Beresewicz, M. Maczewski, and M. Duda, “Effect of classic preconditioning and diazoxide on endothelial function and O2- and NO generation in the post-ischemic guinea-pig heart,” Cardiovascular Research, vol. 63, no. 1, pp. 118–129, 2004. View at Publisher · View at Google Scholar
  249. M. W. Broadhead, R. K. Kharbanda, M. J. Peters, and R. J. MacAllister, “KATP channel activation induces ischemic preconditioning of the endothelium in humans in vivo,” Circulation, vol. 110, no. 15, pp. 2077–2082, 2004. View at Publisher · View at Google Scholar · View at Scopus
  250. S. P. Loukogeorgakis, R. Williams, A. T. Panagiotidou et al., “Transient limb ischemia induces remote preconditioning and remote postconditioning in humans by a KATP channel-dependent mechanism,” Circulation, vol. 116, no. 12, pp. 1386–1395, 2007. View at Publisher · View at Google Scholar · View at Scopus
  251. D. B. Zorov, M. Juhaszova, and S. J. Sollott, “Mitochondrial ROS-induced ROS release: an update and review,” Biochimica et Biophysica Acta, vol. 1757, no. 5-6, pp. 509–517, 2006. View at Publisher · View at Google Scholar · View at Scopus
  252. A. K. Doughan, D. G. Harrison, and S. I. Dikalov, “Molecular mechanisms of angiotensin II-mediated mitochondrial dysfunction: linking mitochondrial oxidative damage and vascular endothelial dysfunction,” Circulation Research, vol. 102, no. 4, pp. 488–496, 2008. View at Publisher · View at Google Scholar · View at Scopus
  253. C. C. Poon, S. W. Seto, A. L. Au et al., “Mitochondrial monoamine oxidase-A-mediated hydrogen peroxide generation enhances 5-hydroxytryptamine-induced contraction of rat basilar artery,” British Journal of Pharmacology, vol. 161, no. 5, pp. 1086–1098, 2010. View at Publisher · View at Google Scholar
  254. S. Meresse, M.-P. Dehouck, P. Delorme et al., “Bovine brain endothelial cells express tight junctions and monoamine oxidase activity in long-term culture,” Journal of Neurochemistry, vol. 53, no. 5, pp. 1363–1371, 1989. View at Publisher · View at Google Scholar · View at Scopus
  255. P. Pagliaro, A. Chiribiri, D. Mancardi, R. Rastaldo, D. Gattullo, and G. Losano, “Coronary endothelial dysfunction after ischemia and reperfusion and its prevention by ischemic preconditioning,” Italian Heart Journal, vol. 4, no. 6, pp. 383–394, 2003. View at Google Scholar · View at Scopus
  256. M. N. Sack, “Mitochondrial depolarization and the role of uncoupling proteins in ischemia tolerance,” Cardiovascular Research, vol. 72, no. 2, pp. 210–219, 2006. View at Publisher · View at Google Scholar · View at Scopus
  257. R. S. Richardson, A. J. Donato, A. Uberoi et al., “Exercise-induced brachial artery vasodilation: role of free radicals,” American Journal of Physiology—Heart and Circulatory Physiology, vol. 292, no. 3, pp. H1516–H1522, 2007. View at Publisher · View at Google Scholar · View at Scopus
  258. N. P. Andrews, A. Prasad, and A. A. Quyyumi, “N-acetylcysteine improves coronary and peripheral vascular function,” Journal of the American College of Cardiology, vol. 37, no. 1, pp. 117–123, 2001. View at Publisher · View at Google Scholar · View at Scopus
  259. T. J. Kizhakekuttu, J. Wang, K. Dharmashankar et al., “Adverse alterations in mitochondrial function contribute to type 2 diabetes mellitus-related endothelial dysfunction in humans,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 32, no. 10, pp. 2531–2539, 2012. View at Publisher · View at Google Scholar · View at Scopus
  260. A. Szewczyk, W. Jarmuszkiewicz, A. Koziel et al., “Mitochondrial mechanisms of endothelial dysfunction,” Pharmacological Reports, vol. 67, no. 4, pp. 704–710, 2015. View at Publisher · View at Google Scholar · View at Scopus